Stock Earnings

Question 1

What are Salarius Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Salarius Pharmaceuticals Inc has a total asset of $3, Net loss of $-5

Question 2

What are the key financial ratios for SLRX?

Accepted Answer

Salarius Pharmaceuticals Inc's Current ratio is 3, has a Net margin is 0, sales per share of $0.

Question 3

How is Salarius Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Salarius Pharmaceuticals Inc data is not available.

Question 4

Is Salarius Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Salarius Pharmaceuticals Inc has a net loss of $-5

Question 5

Does Salarius Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Salarius Pharmaceuticals Inc has liability of 1

Question 6

How many outstanding shares for Salarius Pharmaceuticals Inc?

Accepted Answer

Salarius Pharmaceuticals Inc has a total outstanding shares of 0.09

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	1	5
Revenue Growth (YoY)	--	--	--	-100%	-80%	67%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	4	4	5	7	6	6
Research & Development	--	0	7	15	8	6
Operating Expenses	5	5	12	22	14	13
Other Non Operating Income (Expenses)	--	--	--	--	0	0
Pretax Income	-5	-5	-12	-31	-12	-7
Income Tax Expense	--	--	--	--	--	--
Net Income	-5	-5	-12	-31	-12	-7
Net Income Growth	25%	-57.99%	-61%	158%	71%	17%
Shares Outstanding (Diluted)	0.48	0.06	0.02	0.01	0.01	0
Shares Change (YoY)	463%	136%	54%	28%	165%	373%
EPS (Diluted)	-10.39	-86.91	-460.95	-1,784.75	-925.9	-1,493
EPS Growth	-82%	-81%	-74%	93%	-38%	-77%
Free Cash Flow	-4	-4	-12	-17	-10	-10
Free Cash Flow Per Share	-8.3	-62.3	-441.17	-960.45	-724.63	-1,923.07
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	-1,200%	-140%
Profit Margin	0%	0%	0%	0%	-1,200%	-140%
Free Cash Flow Margin	0%	0%	0%	0%	-1,000%	-200%
EBITDA	-5	-5	-12	-22	-12	-7
EBITDA Margin	0%	0%	0%	0%	-1,200%	-140%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-5	-5	-12	-22	-12	-7
EBIT Margin	0%	0%	0%	0%	-1,200%	-140%
Effective Tax Rate	--	--	--	--	--	--

Salarius Pharmaceuticals Inc (SLRX) Price